The evaluation of basic fibroblast growth factor and fibroblastic growth factor receptor 1 levels in saliva and serum of patients with salivary gland tumor

DNA and Cell Biology

Volumn 31, Issue 4, 2012, Pages 520-523

  Huang, Yong Qing ^a   Li, Ya Di ^a   Li, Guo Kai ^b   Jin, Zhe ^c   Ma, Jian ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b Ningxia People's Hospital   (China)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND TUMOR; SENSITIVITY AND SPECIFICITY; SERUM; STATISTICAL SIGNIFICANCE; TUMOR DIAGNOSIS;

AGED; CASE-CONTROL STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MIDDLE AGED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; ROC CURVE; SALIVA; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859736222     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1310     Document Type: Article

References (10)

1. Gravdal, K., Halvorsen, O.J., Haukaas, S.A., and Akslen, L.A. (2006). Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. Virchows Arch 448, 68-74.
2. Hase, T., Kawashiri, S., and Tanaka, A. (2006).Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma. Oral Pathol Med 35, 136-139.
3. Ishizaki, H., Westermark, A., and van Setten, G. (2000). Basic fibroblast growth factor (FGF2) in saliva-physiological and clinical implications. Acta Otolaryngol Suppl 543, 193-195.
4. Kaminska, J., Kowalska, M., and Kotowicz, B. (2006). Pretreatment serum levels of cytokines and cytokine receptors in patients weatures and prognosis,M-CSF an independent prognostic factor. Oncology 70, 115-25.
5. Morikawa, Y., Ishihara, Y., and Tohya, K. (1996). Expression of the FGFR1 in human normal tissues and tumors determined by a new monoclonal antibody. Arch Pathol Lab Med 120, 90-496.
6. Navazesh, M., and Kumar, K.S. (2008). Measuring salivary flow: challenges and opportunities. JADA 139, 35s-40s.
7. Nguyen, M., Watanabe, H., Budson, A.E., Richie, J.P., Hayes, D.F., and Folkman, J. (1994). Elevated levels of an angiogenic peptide basic fibroblast growth factor in the urine of patients with a wide spectrum of cancers. Natl Cancer 86, 356-361.
8. Nicholas, J.H. (2007). The fibroblast growth factor (FGF)-FGF receptor complex: progress towards the physiological state. Top Curr Chem 272, 83-116.
9. Pieter, B.D.D., Nel, J., and Hans, J. (2007). Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism. Human Pathol 38, 79-85.
10. Pezelj-Ribaric, S., Prso, I.B., Abram, M., Glazar, I., Brumini G., Simunovic-Soskic, M. (2004). Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediat Inflamm 13, 131-133.